Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 3
1960 1
1964 4
1965 14
1966 226
1967 343
1968 404
1969 409
1970 434
1971 432
1972 431
1973 482
1974 531
1975 577
1976 653
1977 681
1978 639
1979 701
1980 693
1981 745
1982 704
1983 816
1984 745
1985 714
1986 748
1987 692
1988 642
1989 687
1990 605
1991 684
1992 658
1993 669
1994 669
1995 674
1996 650
1997 571
1998 553
1999 627
2000 544
2001 555
2002 536
2003 541
2004 553
2005 536
2006 617
2007 611
2008 646
2009 674
2010 688
2011 655
2012 705
2013 661
2014 629
2015 693
2016 589
2017 508
2018 511
2019 356
2020 29
Text availability
Article attribute
Article type
Publication date

Search Results

31,138 results
Results by year
Filters applied: . Clear all
Page 1
Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-╬▒Is), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.
Nardone B, Orrell KA, Vakharia PP, West DP. Nardone B, et al. Expert Opin Drug Saf. 2018 Feb;17(2):139-147. doi: 10.1080/14740338.2018.1400530. Epub 2017 Nov 8. Expert Opin Drug Saf. 2018. PMID: 29103328 Review.
Derisking Drug-Induced Carcinogenicity for Novel Therapeutics.
Moggs JG, MacLachlan T, Martus HJ, Bentley P. Moggs JG, et al. Trends Cancer. 2016 Aug;2(8):398-408. doi: 10.1016/j.trecan.2016.07.003. Epub 2016 Jul 30. Trends Cancer. 2016. PMID: 28741493 Review.
Arsenic and the skin.
Schwartz RA. Schwartz RA. Int J Dermatol. 1997 Apr;36(4):241-50. doi: 10.1046/j.1365-4362.1997.00101.x. Int J Dermatol. 1997. PMID: 9169318 Review. No abstract available.
31,138 results
Jump to page
Feedback